The papilla as screening parameter for early diagnosis of glaucoma;Die papille als screening-parameter für die früherkennung des glaukoms

Deutsches Arzteblatt

Volumn 105, Issue 34-35, 2008, Pages 583-589

  Michelson, Georg ^a   Hornegger, Joachim ^b   Wärntges, Simone ^a   Lausen, Berthold ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Early detection of disease; Glaucoma; Ophthalmology; Prevention; Telemedicine

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROSTAGLANDIN DERIVATIVE;

BLINDNESS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ECONOMIC ASPECT; EVIDENCE BASED PRACTICE; EYE EXAMINATION; FAMILY HISTORY; FUNCTIONAL DISEASE; GLAUCOMA; HEALTH ECONOMICS; HIGH RISK POPULATION; HUMAN; INFORMATION RETRIEVAL; INTRAOCULAR PRESSURE; LOW LEVEL LASER THERAPY; MEDICAL LITERATURE; OCULOPLETHYSMOGRAPHY; OPHTHALMOSCOPY; REVIEW; SCREENING; SENSITIVITY AND SPECIFICITY; TRABECULOPLASTY;

EID: 54249117240     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2008.0583     Document Type: Review

References (25)

1. Quigley A: Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389-93.
2. Quigley HA, Vitale S: Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci 1997; 38: 83-91.
3. Wensor MD, McCarty CA, Stanislavsky YL, Livingston PM, Taylor HR: The prevalence of glaucoma in the Melbourne visual impairment project. Ophthalmology 1998; 105: 733-9.
4. Statistisches Bundesamt: Bevölkerungsfortschreibung Fachserie 1 Reihe 1.3 - 2005. Wiesbaden 2006. www-ec.destatis.de/csp/shop/sfg/bpm.html.cms. cBroker.cls?cmspath=struktur,vollanzeige.csp&ID=1019551
5. Statistisches Bundesamt: Bevölkerung Deutschlands bis 2050-11. Koordinierte Bevölkerungsvorausberechnung. Wiesbaden 2006. www-ec. destatis.de/csp/shop/sfg/bpm.html.cms.cBroker.cls?cmspath=struktur,vollanzeige. csp&ID=1020576
6. BVA (Berufsverband der Augenärzte Deutschlands e.V.), DOG (Deutsche Ophthalmologische Gesellschaft e.V): Augenärzte informieren: Glaukom (grüner Star) www.augeninfo.de/patinfo/patinfo.php
7. Quigley HA: Open-angle glaucoma. N Engl J Med 1993; 328: 1097-106.
8. Mitchell P, Smith W, Attebo K, Healey PR: Prevalence of open-angle glaucoma in Australia. The Blue Mountains eye study. Ophthalmology 1996; 103: 1661-9.
9. Antony K, Genser D, Fröschl B: Erkennungsgüte und Kosteneffektivität von Screeningverfahren zur Erfassung von primären Offenwinkelglaukomen. HTA-Bericht. http://gripsdb.dimdi.de/de/hta/hta_berichte/ hta144_bericht_de.pdf
10. Knauer C, Pfeiffer N: Erblindung in Deutschland - heute und 2030 [Blindness in Germany - today and in 2030]. Ophthalmologe 2006; 103: 735-41.
11. Quigley HA, Broman AT: The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-7.
12. BVA (Berufsverband der Augenärzte Deutschlands e.V.), DOG (Deutsche Ophthalmologische Gesellschaft e.V.): Detektion des primären Offenwinkelglaukoms (POWG): Glaukom-Screening von Risikogruppen, Glaukomverdacht, Glaukomdiagnose, Leitlinie Nr. 15c. www.augeninfo.de/leit/ leit15c.htm
13. Lamoureux EL, Lo K, Ferraro JG et al.: The agreement between the Heidelberg retina tomograph and a digital nonmydriatic retinal camera in assessing area cup-to-disc ratio. Invest Ophthalmol Vis Sci 2006; 47: 93-8.
14. Yamada N, Chen PP, Mills RP et al.: Screening for glaucoma with frequency-doubling technology and Damato campimetry. Arch Ophthalmol 1999; 117: 1479-84.
15. Medeiros FA, Zangwill LM, Bowd C, Sample PA, Weinreb RN: Influence of disease severity and optic disc size on the diagnostic performance of imaging instruments in glaucoma. Invest Ophthalmol Vis Sci 2006; 47: 1008-15.
16. Robin TA, Muller A, Rait J, Keeffe JE, Taylor HR, Mukesh BN: Performance of community-based glaucoma screening using frequency doubling technology and Heidelberg retinal tomography. Ophthalmic Epidemiol 2005;12: 167-78.
17. Tuck MW, Crick RP: The cost-effectiveness of various modes of screening for primary open angle glaucoma. Ophthalmic Epidemiol 1997; 4: 3-17.
18. Conseil d'évaluation des technologies de la santé du Québec (CETS). The screening of primary open-angle glaucoma. Montreal: CETS, 1995, xvi, 93. www.aetmis.gouv.qc.ca/site/download.php?f= d7375b87adf105a0600de66893aa64b7
19. Gemeinsamer Bundesausschuss: Ein Glaukom-Screening ist nicht sinnvoll. www.g-ba.de/informationen/aktuell/pressemitteilungen/62/
20. The AGIS Investigators: "The advanced glaucoma interventions study 7. The relationship between control of intraocular pressure and visual field deterioration". Am J Ophthalmol 2000; 130: 429-40.
21. U.S. Preventive Services Task Force: Screening for glaucoma: recommendation statement. AHRQ publication No. 04-0548-A. Agency for Healthcare Research and Quality. www.ahrq.gov/clinic/uspstf05/glaucoma/glaucrs.htm
22. Mardin CY, Horn FK, Jonas JB, Budde WM: Preperimetric glaucoma diagnosis by confocal scanning laser tomography of the optic disc. Br J Ophthalmol 1999; 83: 299-304.
23. Harasymowycz PJ, Papamatheakis DG, Fansi AK, Gresset J, Lesk MR: Validity of screening for glaucomatous optic nerve damage using confocal scanning laser ophthalmoscopy (Heidelberg retina tomograph II) in high-risk populations: a pilot study. Ophthalmology 2005; 112: 2164-71.
24. Yamada N, Chen PP, Mills RP et al.: Glaucoma screening using the scanning laser polarimeter. J Glaucoma 2000; 9: 254-61.
25. Ivers RQ, Optom B, Macaskill P, Cumming RG, Mitchell P: Sensitivity and specificity of tests to detect eye disease in an older population. Ophthalmology 2001; 108: 968-75.